Controversy Over ‘Morning After Pill’ Status As Prescription Medication

Emergency contraception became a hot topic in South Korea last summer after the Ministry of Food and Drug Safety’s decision to continue its policy of no over-the-counter sales at pharmacies of what is commonly referred to as the “morning-after pill.” Following the ruling, a growing number of Korean women, & several women’s rights groups, voiced their demands for non-prescription access to the medication. The Korea Herald reported on the decision and subsequent public fallout, and Herald writer Claire Lee spoke with Korea FM reporter Chance Dorland about her reporting and the arguments used both for and against making non-prescription, emergency contraception pills available in the ROK. Korea FM also spoke with US-based Reproductive Health Access Project Executive Director Lisa Maldonado to gain perspective on how emergency contraception is viewed outside of South Korea.

This episode is brought to you by Podcast Assist & its $30 per hour flat rate podcasting voice overs, editing, mastering, transcriptions & even hosting (select a topic, they’ll create & host the podcast). Visit Facebook.com/PodcastAssist for more information. 

If the audio player doesn’t load, stream the episode online here or download the full episode here.

Interview answers, both in written & audio form, have been edited for length & clarity.

Rate & Review this podcast at bit.ly/KFMReview

Subscribe to Korea FM Talk Radio & News Podcasts via:

iTunes 96x33   Subscribe On Android      Stitcher 96x33   Tune In Smaller   YouTube 79x33   RSS 83x33

Like us on Facebook  Patreon 728x90

Listen to Korea FM Talk Radio & News Podcasts online via:
Overcast – http://bit.ly/KFMovercast
Stitcher – http://bit.ly/KFMstitcher
audioBoom – http://bit.ly/KFMaudioBoom
Player FM – http://bit.ly/KFMplayerfm
Tunein – http://bit.ly/KFMtunein
Acast – http://bit.ly/KFMacast1
RSS – http://bit.ly/KFMrss
iTunes – http://apple.co/1O91B39

Korea FM banner-ad

You may also like...

Add a Comment

Your email address will not be published.